![Christopher Degnan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Degnan
Finanzdirektor/CFO bei
UROGEN PHARMA LTD.
Vermögen: 87 187 $ am 31.07.2026
Profil
Christopher Degnan currently works at UroGen Pharma Ltd., as Chief Financial & Accounting Officer from 2024.
Mr. Degnan also formerly worked at AstraZeneca PLC, as Senior Finance Director from 2004 to 2014, Endo International Plc, as Chief Financial Officer from 2016 to 2018, Endo Pharmaceuticals, Inc., as Chief Financial Officer & Vice President-Finance, Verrica Pharmaceuticals, Inc., as Chief Financial & Accounting Officer from 2018 to 2019, and Galera Therapeutics, Inc., as Chief Financial & Accounting Officer.
Mr. Degnan received his undergraduate degree from the University of Notre Dame.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.01.2026 | 2.280 ( 0 % ) | 87 187 $ | 31.07.2026 |
Aktive Positionen von Christopher Degnan
| Unternehmen | Position | Beginn |
|---|---|---|
| UROGEN PHARMA LTD. | Finanzdirektor/CFO | 08.10.2024 |
Ehemalige bekannte Positionen von Christopher Degnan
| Unternehmen | Position | Ende |
|---|---|---|
| GALERA T COM USD0. | Finanzdirektor/CFO | 31.08.2024 |
| VERRICA PHARMACEUTICALS INC. | Finanzdirektor/CFO | 07.10.2019 |
| ENDO INTERNATIONAL PLC | Finanzdirektor/CFO | 01.03.2018 |
| ASTRAZENECA PLC | Finanzdirektor/CFO | 01.11.2014 |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Finanzdirektor/CFO | - |
Ausbildung von Christopher Degnan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
72
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galera Therapeutics, Inc.
 Galera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs to reduce normal tissue toxicity from radiotherapy | Health Technology |
Endo International Plc
 Endo International Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures immunology, urology, hepatology, generics & sterile injectables therapeutics products | Health Technology |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
UroGen Pharma Ltd.
 UroGen Pharma Ltd. BiotechnologyHealth Technology Develops therapies for urological pathologies | Health Technology |
Verrica Pharmaceuticals, Inc.
 Verrica Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
